Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota: A new insight into lung diseases
Peijun Ma, Mengmeng Wang, Yun Wang
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113810-113810
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Role of gut microbiota in infectious and inflammatory diseases
Miriãn Ferrão Maciel-Fiuza, Guilherme Cerutti Müller, Daniel Marques Stuart Campos, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 82
Unveiling the therapeutic symphony of probiotics, prebiotics, and postbiotics in gut-immune harmony
Pengjun Zhou, Chunlan Chen, Sandip Patil, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 55
Antibiotics and the gut microbiome: Understanding the impact on human health
Rahul Harikumar Lathakumari, K.V. Leela, Abhishek Satheesan, et al.
Medicine in Microecology (2024) Vol. 20, pp. 100106-100106
Open Access | Times Cited: 25
The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics
Georgia Saxami, Evangelia N. Kerezoudi, Christos Eliopoulos, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2023-2023
Open Access | Times Cited: 27
Gut-derived immune cells and the gut-lung axis in ARDS
Mairi Ziaka, Aristomenis K. Exadaktylos
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 14
The mechanism of gut-lung axis in pulmonary fibrosis
Yawei Dong, Lanlan He, Zhongbo Zhu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 11
Pathophysiology of acute lung injury in patients with acute brain injury: the triple-hit hypothesis
Mairi Ziaka, Aristomenis K. Exadaktylos
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 10
Fecal Microbiota Strongly Correlates with Tissue Microbiota Composition in Colorectal Cancer but Not in Non-Small Cell Lung Cancer
Juan Vicente-Valor, Sofía Tesolato, Mateo Paz-Cabezas, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 717-717
Open Access | Times Cited: 1
Lung microbiome and origins of the respiratory diseases
José Ernesto Belizário, Miguel Garay-Malpartida, Joel Faintuch
Current Research in Immunology (2023) Vol. 4, pp. 100065-100065
Open Access | Times Cited: 19
Revealing a causal relationship between gut microbiota and lung cancer: a Mendelian randomization study
Yingchen Li, Ke Wang, Yuchong Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 16
A Lactobacillus Combination Ameliorates Lung Inflammation in an Elastase/LPS—induced Mouse Model of Chronic Obstructive Pulmonary Disease
Huan‐Ting Shen, Yi‐Ting Fang, Wan-Hua Tsai, et al.
Probiotics and Antimicrobial Proteins (2024)
Open Access | Times Cited: 7
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response
Hao Zhang, Li Fu, Xinwen Leiliang, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1130-1167
Open Access | Times Cited: 7
Bibliometric analysis of intestinal microbiota and lung diseases
Wei‐Ting Sun, Tong Zhou, Peng Ding, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 6
The Influence of the Gut Microbiota on Host Health: A Focus on the Gut–Lung Axis and Therapeutic Approaches
Amal S. Alswat
Life (2024) Vol. 14, Iss. 10, pp. 1279-1279
Open Access | Times Cited: 6
The roles of gut microbiome and metabolites associated with skin photoaging in mice by intestinal flora sequencing and metabolomics
Liping Qu, Xiao Ma, Feifei Wang
Life Sciences (2024) Vol. 341, pp. 122487-122487
Closed Access | Times Cited: 5
Evidence of Lung-Gut Co-Treatment: Total Saponins of Siraitiae Fructus Alleviate Lung and Intestinal Injuries in Acute Lung-Injured Rats and Influenza Virus-Infected Mice by Regulating Cytokines and Enhancing Mucosal Barrier
Jiaqian Chen, Yuhang Ma, Xiaonan Chen, et al.
(2025)
Closed Access
The role of the microbiota and metabolites in the treatment of pulmonary fibrosis with UC-MSCs: Integrating fecal metabolomics and 16S rDNA analysis
Yukai Luo, Shuang Zhou, Xiaojing Zhang, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313989-e0313989
Open Access
Clinical significance of perioperative probiotic intervention on recovery following intestinal surgery
Yang Wu, Xin Zhang, G Wang, et al.
World Journal of Gastrointestinal Surgery (2025) Vol. 17, Iss. 2
Closed Access
The association of gut microbiota, immunocyte dynamics, and protein–protein ratios with tuberculosis susceptibility: a Mendelian randomization analysis
Xin Ma, Weijie Ma, Liangyu Zhu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Effect of Toxocara canis infection on liver and lung microbial flora diversity and composition in dogs.
Na Wang, Soben Sieng, Tian Liang, et al.
PubMed (2025) Vol. 32, pp. 17-17
Closed Access
Assessing causal relationships between gut microbiotas, metabolites, and pulmonary arterial hypertension through univariate Mendelian randomization study and bioinformatics analysis
Dongrui Xu, Hong Liu, Jiankang Yang
Journal of Hypertension (2025)
Closed Access
Total saponins from Siraitiae Fructus alleviate lung and intestinal injuries in rats with acute lung injury and mice infected with the influenza virus by regulating cytokines and enhancing the mucosal barrier.
Zong‐Jin Pu, Yuhang Ma, Xiaonan Chen, et al.
Food Bioscience (2025), pp. 106538-106538
Closed Access
Health benefits of medicinal plant natural products via microbiota-mediated different gut axes
Xiang Li, Yufan Liu, Ning Liu, et al.
Pharmacological Research (2025), pp. 107730-107730
Open Access
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis
Mengdi Sun, Feiyu Zhang, Fang Lü, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Urolithin A Protects against Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Smooth Muscle Cell Pyroptosis via AMPK/NF-κB/NLRP3 Signaling
Xinjie He, Zhinan Wu, Jinyao Jiang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8246-8246
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top